Growth Metrics

Vycor Medical (VYCO) Capital Expenditures Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Vycor Medical - - 375,153.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 80,350.00%
Dec 31, 2024 -100.03%
Dec 31, 2023 1,933.54%
Dec 31, 2022 -2.22%
Sep 30, 2022 -101.49%
Dec 31, 2021 -116.41%
Sep 30, 2021 -36.42%
Jun 30, 2021 146.50%
Mar 31, 2021 -48.66%
Dec 31, 2020 -93.87%
Sep 30, 2020 -36.24%
Jun 30, 2020 602.24%
Mar 31, 2020 637.09%
Dec 31, 2019 353.01%
Sep 30, 2019 142.14%
Jun 30, 2019 -101.82%
Mar 31, 2019 -52.19%
Dec 31, 2018 -69.83%
Sep 30, 2018 -90.92%
Jun 30, 2018 120.64%
Mar 31, 2018 -81.45%
Dec 31, 2017 -21.42%
Sep 30, 2017 800.19%
Jun 30, 2017 445.31%
Mar 31, 2017 315.39%
Dec 31, 2016 -82.09%
Sep 30, 2016 -61.00%
Jun 30, 2016 -78.13%
Mar 31, 2016 37.41%
Sep 30, 2015 -54.88%
Jun 30, 2015 -56.78%
Mar 31, 2015 -57.83%
Sep 30, 2014 -33.55%
Jun 30, 2014 221.96%
Mar 31, 2014 194.48%
Dec 31, 2013 392.85%
Sep 30, 2013 2,562.67%
Jun 30, 2013 4.85%
Mar 31, 2013 25.05%
Dec 31, 2012 140.81%
Sep 30, 2012 -62.06%
Jun 30, 2012 -35.49%
Mar 31, 2012 566.14%
Dec 31, 2011 -199.60%